Tao Chen

High Impact

Researcher

NCTR

Also affiliated: Ningbo University (2024–2025); Tongji University (2006–2025); Beijing Tongren Hospital (2016); Fujian Medical University (2023); Apple (Israel) (2018); United States Food and Drug Administration (2025); Ministry of Education of the People's Republic of China (2018); Kyushu University (2001–2020); Harvard University (2016); Xidian University (2018); National University of Singapore (2019); City University of Hong Kong (2024–2025); Guangdong Medical College (2021); Second Military Medical University (2017); Zunyi Medical University (2019–2020); Shanghai Jiao Tong University (2025); Capital Medical University (2016); King's College London (2017); Chinese Center For Disease Control and Prevention (2012); Liverpool School of Tropical Medicine (2022); Chinese Academy of Medical Sciences & Peking Union Medical College (2011); Yichun University (2025); Southwestern University of Finance and Economics (2009); Sichuan University (2020–2025); Edinburgh Napier University (2012–2019); National Health and Family Planning Commission (2019); Diabetes Australia (2021); Chinese PLA General Hospital (2020–2024); Guangzhou Sport University (2025); Sichuan Agricultural University (2009); Haikou City People's Hospital (2014); West China Hospital of Sichuan University (2020–2025); Ganzhou People's Hospital (2024); Xinjiang Uygur Autonomous Region Disease Prevention and Control Center (2022); Jiangsu University of Science and Technology (2023–2024); Counseling Center (2020); 302 Military Hospital of China (2021); Gannan Medical University (2025); Changhai Hospital (2017); First Affiliated Hospital of Fujian Medical University (2023); First Affiliated Hospital of Xi'an Jiaotong University (2011–2019); Shanghai Pulmonary Hospital (2016–2025); State Council of the People's Republic of China (2019); Ningxia Medical University (2019); Hainan General Hospital (2014); Shanghai First People's Hospital (2025); Chinese Academy of Agricultural Sciences (2024); Sericultural Research Institute (2023–2025); People's Government of Shaanxi Province (2019); National Institute for Viral Disease Control and Prevention (2013–2019); Ministry of Education (2019); The First People's Hospital of Guiyang (2024); Ministry of Education (2019); Ministry of Agriculture and Rural Affairs (2024); Harvard Stem Cell Institute (2016); Second Affiliated Hospital of Zhejiang University (2021); Tongji Hospital (2020); Chinese People's Liberation Army (2020); Fu Wai Hospital (2009); Hainan 301 Hospital (2014); Affiliated Hospital of Zunyi Medical College (2019–2020); Dong-A University (2020); Chengdu University of Traditional Chinese Medicine (2022); Shandong Agricultural University (2019); University of Birmingham (2009); Xi'an Jiaotong University (2019); American College of Surgeons (2015)

Faculty Researcher

29 h-index 151 pubs 2,706 cited

Upstream record may be merged OpenAlex, the source of these figures, lists 68 institutions in 11 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Tao Chen's research has focused on understanding risk factors and outcomes for various health conditions, with a particular emphasis on dementia, functional disability, and cancer. Chen has contributed to large-scale collaborative efforts, including the COSMIC consortium, which analyzes individual participant data from numerous cohorts globally to investigate dementia risk factors and lifestyle influences. This work involves analyzing large datasets to identify patterns and associations related to health outcomes.

Chen's publications also address the global burden of infectious diseases, such as syphilis, and explore the utility of medical imaging and predictive modeling in cancer diagnostics. For instance, research includes evaluating the accuracy of chest CT scans for thoracic sarcoidosis and developing deep learning models for predicting nodal metastasis in lung cancer. Additionally, Chen has investigated methods for assessing frailty in critically ill patients and the predictive value of physical function measures for older adults. This body of work highlights an interest in quantitative health research, meta-analyses, and the application of advanced analytical techniques to medical data.

Metrics

h-index: 29
Publications: 151
Citations: 2,706

Selected Publications

N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA (2025)

Chemico-Biological Interactions 2 citations DOI OpenAlex
Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing (2025)

Toxicology Letters 2 citations DOI OpenAlex
Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities (2025)

Toxicological Sciences 1 citation DOI OpenAlex
Application of duplex sequencing to evaluate mutagenicity of aristolochic acid and methapyrilene in Fisher 344 rats (2024)

Food and Chemical Toxicology 4 citations DOI OpenAlex